Effect of cyclosporine on regulatory T cells and Foxp3 in the peripheral blood of children with chronic aplastic anemia

WANG Xi-Ge; WANG Meng; LIU Song; WANG Xiao-Ge; QIAO Jun-Ying; CAO Yi-Ming; ZHOU Yu-Jie; YANG Juan; ZHAO Xiao-Ming

PDF(977 KB)

Chinese Journal of Contemporary Pediatrics ›› 2011, Vol. 13 ›› Issue (12) : 936-939.

CLINICAL RESEARCH

Effect of cyclosporine on regulatory T cells and Foxp3 in the peripheral blood of children with chronic aplastic anemia

WANG Xi-Ge, WANG Meng, LIU Song, WANG Xiao-Ge, QIAO Jun-Ying, CAO Yi-Ming, ZHOU Yu-Jie, YANG Juan, ZHAO Xiao-Ming

Author information +

History +

Abstract

OBJECTIVE: To explore the expression diversification of CD4+CD25+CD127low regulatory T (Treg) cells and Foxp3 mRNA in the peripheral blood of children with aplastic anemia after the treatment with cyclosporine. METHODS: Fifty children with chronic aplastic anemia were enrolled, among whom 30 received cyclosporine treatment (cyclosporine group) and 20 were treated with conventional methods (conventional group). Twenty healthy children were enrolled as the control group. The expression of CD4+CD25+CD127low Treg cells was detected by flow cytometry. The expression of Foxp3 mRNA was detected by real-time Q-PCR. RESULTS: The expressions of Foxp3 mRNA and CD4+CD25+CD127lowTreg cells showed no significant difference between the cyclosporine and the control groups 6 months after treatment. On the contrary, there were significantly lower expressions of both in the conventional group than in the control group (P<0.05). Meanwhile, the cyclosporine group had significantly higher expressions of Foxp3 mRNA and CD4+CD25+CD127low Treg cells than the conventional group (P<0.05). CONCLUSIONS: The expressions of CD4+CD25+CD127low Treg cells and Foxp3 mRNA in children with aplastic anemia increase after cyclosporine treatment.

Key words

Aplastic anemia / Regulatory T cell / Foxp3 mRNA / Cyclosporine / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

WANG Xi-Ge, WANG Meng, LIU Song, WANG Xiao-Ge, QIAO Jun-Ying, CAO Yi-Ming, ZHOU Yu-Jie, YANG Juan, ZHAO Xiao-Ming. Effect of cyclosporine on regulatory T cells and Foxp3 in the peripheral blood of children with chronic aplastic anemia[J]. Chinese Journal of Contemporary Pediatrics. 2011, 13(12): 936-939

References

［1］谢晓恬.儿童再生障碍性贫血的诊断与治疗［J］.实用儿科临床杂志，2009，24(3): 234-237.

［2］何广胜，周玲，吴德沛，孙爱宁，苗瞄，王秀丽，等.CD4+调节性 T细胞在再生障碍性贫血免疫发病中的作用［J］.中国实用内科杂志，2007，27(20):1599-1601.

［3］黄永兰，黄绍良，梁蔚文，魏菁.再生障碍性贫血患儿CD4+CD25+T细胞及TGF-β1 Flt-3L水平变化的意义［J］.中国实用儿科杂志，2007，22(2):130-133.

［4］李玉云，王卫国，张强，陈乐，马芳，马黎丽.CD4+CD25+Treg细胞和IL-21与再生障碍性贫血发病关系的探讨［J］.中国实用儿科杂志，2010，31(4):269-270.

［5］Solomou EE, Rezvani K, Mielke S, Malide D, Keyvanfar K, Visconte V, et al. Deficient CD4+CD25+FOXP3+ T regulatory cells in acquired aplastic anemia［J］. Blood, 2007, 110(5): 1603-1606.

［6］王西阁，王晓格，栾斌，胡姬婷.调节性T细胞及Foxp3基因在再生障碍性贫血患儿外周血中的变化及意义［J］.中国当代儿科杂志，2010，12(4): 241-243.

［7］王西阁，曹祎明，王晓格.CD4+CD25int/highCD127low调节性T细胞在再生障碍性贫血患儿中的检测及意义［J］.中国当代儿科杂志，2011，13(4):292-295.

［8］许崇艳.再生障碍性贫血的免疫抑制治疗［J］. 中国实验血液学杂志，2005，13(2): 348.

［9］中华医学会儿科分会血液组,中华儿科杂志编委会.小儿再生障碍性贫血的诊疗建议［J］.中华儿科杂志, 2001, 39(7): 422-423.

［10］王雪梅,韩梅,肖中平,陈琳.环孢素和雄激素联合治疗再生障碍性贫血疗效观察［J］.中国误诊学杂志,2007,7(3): 453.

［11］Fiedler B, Wollert KC. Inter ference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiacmy ocytes［J］. Cardiovasc Res, 2004, 63(3): 450-457.

［12］Bayer AL, Yu A, Malek TR. Function of the IL-2R for thymic and peripheral CD4+ CD25+ Foxp3+ T regulatory cells［J］. J Immunol, 2007, 178(7): 4062-4071.

［13］Lutsiak ME, Semnani RT, De Pascalis R, Kashmiri SV, Schlom J, Sabzevari H. Inhibition of CD4+CD25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide［J］. Blood, 2005, 105(7): 2862-2868.

［14］Godfrey WR, Spoden DJ, Ge YG, Baker SR, Liu B, Levine BL, et al.Cord blood CD4+CD25+ derived T regulatory cells linesexpress FOXP3 protein and manifest potent suppressor function［J］. Blood, 2005, 105(2): 750-758.

［15］Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells［J］. Nax Immunol, 2003, 4(4): 330-336.

［16］Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for scurfin in CD4+CD25+T regulatory cells［J］. Nat Immunol, 2003, 4(4): 337-342.

［17］Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S, et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+regulatory T cells［J］. Int Immunol, 2004, 16(11): 1643-1656.

［18］Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, et al.Defective regulatory and effector T cell functions in patients with FOXP3 mutations［J］. J Clin Invest, 2006, 116(6): 1713-1722.

［19］Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance(IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis［J］. Curr Opin Rheumatol, 2003, 15(4): 430-435.

［20］Unterberger C, Staples KJ, Smallie T, Williams L, Foxwell B, Schaefer A, et al. Role of STAT3 in glucocorticoid induced expression of thehuman IL-10 gene［J］. Mol Immunol, 2008, 45(11): 3230-3237.